AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 67 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,959,730 | +59.1% | 1,719,061 | +27.7% | 0.01% | +71.4% |
| Q2 2023 | $1,231,619 | +83.3% | 1,346,032 | +12.3% | 0.01% | +75.0% |
| Q1 2023 | $671,765 | -42.2% | 1,198,724 | -40.5% | 0.00% | -50.0% |
| Q4 2022 | $1,162,521 | +80.0% | 2,014,767 | -1.4% | 0.01% | +60.0% |
| Q3 2022 | $646,000 | +134.9% | 2,042,816 | +162.7% | 0.01% | +150.0% |
| Q2 2022 | $275,000 | -61.1% | 777,617 | -21.0% | 0.00% | -60.0% |
| Q1 2022 | $707,000 | -88.6% | 984,741 | -64.0% | 0.01% | -87.8% |
| Q4 2021 | $6,188,000 | -19.3% | 2,737,900 | +2.8% | 0.04% | -21.2% |
| Q3 2021 | $7,667,000 | -30.4% | 2,662,045 | -8.4% | 0.05% | -30.7% |
| Q2 2021 | $11,019,000 | +22.0% | 2,907,334 | +9.0% | 0.08% | +7.1% |
| Q1 2021 | $9,031,000 | +61.7% | 2,668,029 | +33.7% | 0.07% | +42.9% |
| Q4 2020 | $5,586,000 | +218.8% | 1,994,852 | +185.8% | 0.05% | +172.2% |
| Q3 2020 | $1,752,000 | -72.4% | 697,905 | +49.4% | 0.02% | -73.9% |
| Q2 2020 | $6,344,000 | +68.1% | 467,143 | -6.2% | 0.07% | +43.8% |
| Q1 2020 | $3,773,000 | +65.0% | 497,758 | +37.6% | 0.05% | +118.2% |
| Q4 2019 | $2,286,000 | +209.8% | 361,633 | +137.2% | 0.02% | +120.0% |
| Q2 2019 | $738,000 | -85.9% | 152,461 | -76.1% | 0.01% | -86.7% |
| Q1 2019 | $5,222,000 | +127.6% | 637,560 | +53.7% | 0.08% | +87.5% |
| Q4 2018 | $2,294,000 | -21.4% | 414,852 | +25.5% | 0.04% | -2.4% |
| Q3 2018 | $2,918,000 | +5.9% | 330,452 | +19.7% | 0.04% | -4.7% |
| Q2 2018 | $2,756,000 | +247.1% | 276,153 | +231.4% | 0.04% | +230.8% |
| Q1 2018 | $794,000 | +46.8% | 83,319 | +128.8% | 0.01% | +30.0% |
| Q4 2017 | $541,000 | +26.1% | 36,410 | +67.1% | 0.01% | +25.0% |
| Q3 2017 | $429,000 | +53.2% | 21,790 | +11.9% | 0.01% | +33.3% |
| Q2 2017 | $280,000 | +127.6% | 19,480 | +18.3% | 0.01% | +100.0% |
| Q2 2016 | $123,000 | – | 16,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |